Loading clinical trials...

Perioperative Outcomes of Simultaneous Colorectal and Liver Resections | Clinical Trials | Clareo Health

COMPLETED

Perioperative Outcomes of Simultaneous Colorectal and Liver Resections

Simultaneous Resection of Colorectal Cancer and Synchronous Liver Metastases: What Determines the Risk of Unfavorable Outcomes? A Retrospective International Multicenter Study

NCT05475041•Fondazione Poliambulanza Istituto Ospedaliero

View on ClinicalTrials.gov

Summary

The use of a simultaneous resection in patients with synchronous colorectal liver metastases has increased over the past decades. However, it remains unclear when a simultaneous resection is beneficial and when it should be avoided. The objective of this retrospective study is therefore to compare the outcomes of a simultaneous resection for synchronous colorectal liver metastases in different settings, and to assess which factors are independently associated with unfavorable outcomes.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Elective minimally invasive or open simultaneous resection of colorectal cancer and synchronous colorectal liver metastases

Exclusion Criteria

•(Partially) robotic-assisted or thoracoscopic procedures
•First stage of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)
•Patients that underwent major concurrent procedures

Locations (1)

Fondazione Poliambulanza Istituto Ospedaliero

Brescia, Lombardy, Italy

Key Dates

Start Date

June 30, 2022

Primary Completion Date

July 10, 2022

Completion Date

July 22, 2022

Last Updated

July 26, 2022

Enrollment

766

ACTUAL participants

Conditions

Colorectal Cancer MetastaticSurgical Procedure, Unspecified

Interventions

Major liver resection

PROCEDURE

Technically major liver resection

PROCEDURE

Minimally Invasive Sinus Lift Through the Interradicular Septum

NCT05237570

Bone LossBone Loss, Age-related+2 more

View study

RECRUITINGPHASE1/PHASE2

A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer

NCT05759728

Colorectal Cancer Metastatic

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 26, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Perioperative Outcomes of Simultaneous Colorectal and Liver Resections

Inclusion Criteria

Exclusion Criteria

Minimally Invasive Sinus Lift Through the Interradicular Septum

A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer

COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer

STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer

Continuous Infusions vs Scheduled Bolus Infusions

A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.